Ernexa Therapeutics, Inc. (ERNA)
0.2851
-0.01
(-4.33%)
USD |
NASDAQ |
Feb 27, 16:00
0.2916
+0.01
(+2.28%)
After-Hours: 20:00
Ernexa Therapeutics EPS Diluted (Quarterly) : -0.1507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -0.29 |
| Quince Therapeutics, Inc. | -0.2492 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Tango Therapeutics, Inc. | 0.1431 |
| Aprea Therapeutics, Inc. | -0.4664 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.24M |
| Total Expenses (Quarterly) | 1.24M |
| Enterprise Value | -0.255M |
| Earnings Yield | -910.4% |
| Normalized Earnings Yield | -891.58 |